Acadia Healthcare Company, Inc.
ACHC- Exchange
- Nasdaq
- Industry
- Services-Specialty Outpatient Facilities, NEC
- SEC CIK
- 0001520697
No open-market purchases or sales by Acadia Healthcare Company, Inc. insiders were filed in the last 90 days; 313 institutions reported holding it in 13F filings for Q2 2026, worth $3.97B in total; Greenlight Capital is the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Acadia Healthcare Company, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 285
- +16 vs. Q1 2021
- Shares held
- 90.0M
- −658.0K (−0.7%) vs. Q1 2021
- Total value
- $5.65B
- +$468.7M (+9.1%) vs. Q1 2021
- New holders
- 43
- 106 more added
- Sold out
- 27
- 98 more reduced
2 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACHC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 313 | $3.97B |
| Q1 2026 | 296 | $3.10B |
| Q4 2025 | 255 | $1.73B |
| Q3 2025 | 271 | $2.81B |
| Q2 2025 | 294 | $2.41B |
| Q1 2025 | 292 | $3.03B |
| Q4 2024 | 306 | $3.98B |
| Q3 2024 | 312 | $6.23B |
| Q2 2024 | 305 | $6.52B |
| Q1 2024 | 321 | $7.38B |
| Q4 2023 | 313 | $7.19B |
| Q3 2023 | 294 | $6.43B |
| Q2 2023 | 280 | $7.41B |
| Q1 2023 | 311 | $6.71B |
| Q4 2022 | 346 | $7.53B |
| Q3 2022 | 317 | $7.30B |
| Q2 2022 | 286 | $6.30B |
| Q1 2022 | 287 | $5.92B |
| Q4 2021 | 275 | $5.48B |
| Q3 2021 | 293 | $5.78B |
| Q2 2021 | 285 | $5.65B |
| Q1 2021 | 271 | $5.18B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Acadia Healthcare Company, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −4,400−100.0% | Sold out |
| LS Investment Advisors, LLC | 0 | $0 | 0.00% | −4,028−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −3,826−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −3,806−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −2,600−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −104−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Ameritas Investment Company, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| BBVA USA Bancshares, Inc. | – | – | – | – | Not filed |
| Amundi Asset Management US, Inc. | – | – | – | – | Not filed |